Open Label Extension to Bridging Study CTBM100C2303
Status:
Completed
Trial end date:
2011-10-06
Target enrollment:
Participant gender:
Summary
This was an open-label, single arm (uncontrolled) study in participants suffering from cystic
fibrosis, who had completed their study participation in CTBM100C2303 (all visits) and who
were proven infected with Pseudomonas aeruginosa (P. aeruginosa) at enrollment into
CTBM100C2303.